Morgan Stanley
-
-
-
-
-
-
-
Jazz Pharmaceuticals (JAZZ) Seeds the Xywav Market Causing a Short Term Earnings Reduction - Morgan Stanley
-
-
-
-
-
-
-
UPDATE: Morgan Stanley Upgrades Jazz Pharmaceuticals (JAZZ) to Overweight
-
-
-
-
-
-
-
Jazz Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference
-
-
-
-
-
-
-
Notable Analyst Rating Changes 09/18: (BRCM) (GM) (OCZ) Upgraded; (RIMM) (INTC) (BBBY) Downgraded
-
-
-
-
158,022 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All